Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    November 2018
  1. TIAN X, Zhou Y, Wang Y, Zhang S, et al
    Mitochondrial Dysfunction and Apoptosis are Attenuated upon kappa-Opioid Receptor Activation via AMPK/GSK-3beta Pathway Following Myocardial Ischemia and Reperfusion.
    J Cardiovasc Pharmacol. 2018 Nov 5. doi: 10.1097/FJC.0000000000000635.
    PubMed     Text format     Abstract available


    October 2018
  2. BOOZ GW
    Seizing the Future: What's next for the Journal of Cardiovascular Pharmacology?
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000630.
    PubMed     Text format    


  3. PIQUERAS-FLORES J, Jurado-Roman A, Lopez-Lluva MT, Sanchez-Perez I, et al
    Efficacy and safety of loading doses with P2Y12-receptor antagonists in patients without dual antiplatelet therapy undergoing elective coronary intervention.
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000632.
    PubMed     Text format     Abstract available


  4. YUAN L, Tang C, Li D, Yang Z, et al
    microRNA-18a expression in female coronary heart disease and regulatory mechanism on endothelial cell by targeting estrogen receptorsss.
    J Cardiovasc Pharmacol. 2018 Oct 24. doi: 10.1097/FJC.0000000000000623.
    PubMed     Text format     Abstract available


    June 2018
  5. DIMITROULIS D, Golabkesh M, Naguib D, Knoop B, et al
    Safety and efficacy in Prasugrel vs. Ticagrelor treated ST-elevation myocardial infarction (STEMI) patients.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000609.
    PubMed     Text format     Abstract available


  6. ZHOU L, Liu X, Wang ZQ, Li Y, et al
    Simvastatin Treatment Protects Myocardium in Non-coronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000611.
    PubMed     Text format     Abstract available


    May 2018
  7. VAN TAUNAY JS, Albelda MT, Frias JC, Lipinski MJ, et al
    Biologics and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000595.
    PubMed     Text format     Abstract available


    April 2018
  8. CHEN S, Zhang S, Luan H, Zeng X, et al
    Correlation Between Extended Leukocyte Differential Count and Coronary Artery Disease.
    J Cardiovasc Pharmacol. 2018 Apr 10. doi: 10.1097/FJC.0000000000000582.
    PubMed     Text format     Abstract available


  9. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
    Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    J Cardiovasc Pharmacol. 2018;71:205-214.
    PubMed     Text format     Abstract available


    March 2018
  10. ABOUZAKI NA, Christopher S, Trankle C, Van Tassell BW, et al
    Inhibiting the inflammatory injury following myocardial ischemia reperfusion with plasma derived alpha-1 anti-trypsin: a post-hoc analysis of the VCU-alpha1RT study.
    J Cardiovasc Pharmacol. 2018 Mar 23. doi: 10.1097/FJC.0000000000000583.
    PubMed     Text format     Abstract available


  11. BISGAIER CL, Oniciu DC, Srivastava RAK
    Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 Mar 21. doi: 10.1097/FJC.0000000000000580.
    PubMed     Text format     Abstract available


  12. MOHAMMAD FIC AM, Al-Allawi NA
    CYP2C19 genotype is an independent predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel Post Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2018 Mar 12. doi: 10.1097/FJC.0000000000000577.
    PubMed     Text format     Abstract available


    January 2018
  13. SIGURDSSON MI, Waldron NH, Bortsov AV, Smith SB, et al
    Genomics of Cardiovascular Measures of Autonomic Tone.
    J Cardiovasc Pharmacol. 2018 Jan 3. doi: 10.1097/FJC.0000000000000559.
    PubMed     Text format     Abstract available


    December 2017
  14. ABBATE A
    Why the CANTOS Is a Game Changer in Cardiovascular Medicine.
    J Cardiovasc Pharmacol. 2017;70:353-355.
    PubMed     Text format    


    September 2017
  15. JAZMIN FM, Diana RH, Citali SH, Diego LM, et al
    Sex Differences In Vascular Reactivity To Angiotensin Ii During The Evolution Of Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Sep 29. doi: 10.1097/FJC.0000000000000542.
    PubMed     Text format     Abstract available


    June 2017
  16. ZHONG Y, Zhong P, He S, Zhang Y, et al
    Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
    J Cardiovasc Pharmacol. 2017;69:389-397.
    PubMed     Text format     Abstract available


    May 2017
  17. HARISSEH R, Chiari P, Villedieu C, Sueur P, et al
    Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane.
    J Cardiovasc Pharmacol. 2017;69:326-334.
    PubMed     Text format     Abstract available


  18. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Text format     Abstract available


    April 2017
  19. BEHMENBURG F, Pickert E, Mathes A, Heinen A, et al
    The Cardioprotective Effect of Dexmedetomidine in Rats Is Dose-Dependent and Mediated by BKCa Channels.
    J Cardiovasc Pharmacol. 2017;69:228-235.
    PubMed     Text format     Abstract available


    March 2017
  20. ZHU A, Wei X, Zhang Y, You T, et al
    Propofol Provides Cardiac Protection by Suppressing the Proteasome Degradation of Caveolin-3 in Ischemic/Reperfused Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:170-177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: